Biohaven Ltd. SEC filings BHVN
Biohaven Ltd. has 282 filings in SEC EDGAR's recent list, going back to Jul 1, 2022. Its latest annual report, Form 10-K, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 15, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 4, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 26, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 7, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 9, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2026 | May 26, 2026 |
| 8-K |
Current report
Other events
|
May 5, 2026 | May 4, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 4, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Jan 7, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 22, 2025 | Aug 21, 2025 |
| 8-K |
Current report
Other events
|
Aug 15, 2025 | Aug 15, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 15, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 7, 2025 | May 5, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Apr 28, 2025 | Apr 28, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Other events
|
Oct 2, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 23, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Other events
|
Aug 16, 2024 | Aug 16, 2024 |
| 8-K |
Current report
Other events
|
Aug 16, 2024 | Aug 16, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Other events
|
May 17, 2024 | May 17, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 1, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Other events
|
Apr 22, 2024 | Apr 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 15, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Other events
|
Mar 12, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Other events
|
Oct 5, 2023 | Oct 5, 2023 |
| 8-K |
Current report
Other events
|
Oct 3, 2023 | Oct 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 28, 2023 | Jul 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 31, 2023 | May 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 12, 2023 | May 12, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 4, 2023 | May 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Oct 3, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2022 | Sep 27, 2022 |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BHVN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Virgin Islands, British
- Headquarters
- New Haven, CT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1935979
- Former names
- Biohaven Research Ltd. (until Sep 14, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.